Healthy volunteers help compare two similar drugs in Early-Stage trial
NCT ID NCT02336347
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study enrolled 62 healthy adults to compare how two drugs, AVP-786 and AVP-923, are processed in the body. Participants received both drugs at different times to measure drug levels and safety. The goal was purely to gather information, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AVP-786 (deuterated dextromethorphan/quinidine) and AVP-923 (dextromethorphan/quinidine)
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Covance Dallas Clinical Research Unit
Dallas, Texas, 75247, United States